Impact of Gentamicin-Collagen Sponge (Collatamp) on the Incidence of Sternal Wound Infection in High-Risk Cardiac Surgery Patients: A Propensity Score Analysis
DOI:
https://doi.org/10.1532/HSF98.20121032Abstract
Objective: Local delivery of prophylactic antibiotic to the wound site with an implanted, reabsorbable, gentamicin-containing collagen sponge (Collatamp) is a strategy that has been claimed to prevent sternal wound infection after cardiac surgery. The purpose of this study was to review our experience with Collatamp in cardiac surgery patients deemed at high risk for sternal wound infection.
Methods: From January 2007 to December 2010, Collatamp was used in 107 patients deemed at high risk for sternal wound infection. Applying the propensity score, we matched 97 patients with Collatamp (group I) with 97 patients who did not receive Collatamp (group II). All individuals received routine intravenous antimicrobial prophylaxis. Postoperative wound-infection rates as well as routine outcomes were compared. Information for the study was obtained from the cardiac surgical Patients Analysis and Tracking System (PATS) database and from hospital records.
Results: The superficial sternal wound infection rate was 2.1% (2/97) in group I and 6.2% (6/97) in group II (P = .01). The rates of deep sternal wound infection rate were similar (2.1% versus 3.1%, P = .87). There was no mediastinitis in the study population. In addition, more patients in group II received an intra-aortic balloon pump (5.2% versus 2.1%, P = .04) and underwent hemofiltration (7.2% versus 3.1%, P = .02). No side effects were noted.
Conclusion: Gentamicin-containing collagen sponge (Collatamp) is a useful adjunct to meticulous surgical technique and postoperative wound care in reducing the incidence of sternal wound infection in high-risk cardiac surgery patients. An adequately powered study is needed, however, to validate the safety and efficacy of this strategy.
References
Ariyaratnam P, Bland M, Loubani M. 2010. Risk factors and mortality associated with deep sternal wound infections following coronary bypass surgery with or without concomitant procedures in a UK population: a basis for a new risk model? Interact Cardiovasc Thorac Surg 11:543-6.nAustin PC. 2007. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg 134:1128-35.nBeckmann A, Doebler K, Schaefer E, Koetting J, Gastmeier P, Graf K. 2011. Sternal surgical site infection prevention - is there any room for improvement? Eur J Cardiothorac Surg 40:347-51.nBendavid R. 1997. The Shouldice technique: a canon in hernia repair. Can J Surg 40:199-205.nBennett-Guerrero E, Ferguson TB Jr, et al, for the SWIPE-1 Trial Group. 2010. Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trial. JAMA 304:755-62.nBlaser J, Stone BB, Groner MC, Zinner SH. 1987. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob Agents Chemother 31:1054-60.nBorger MA, Rao V, Weisel RD, et al. 1998. Deep sternal wound infection: risk factors and outcomes. Ann Thorac Surg 65:1050-6.nCayci C, Russo M, Cheema FH, et al. 2008. Risk analysis of deep sternal wound infections and their impact on long-term survival: a propensity analysis. Ann Plast Surg 61:294-301.nChvapil M. Collagen sponge: theory and practice of medical applications. 1977. J Biomed Mater Res 11:721-41.nCorn T. 2010. Treating sternal wound infections after cardiac surgery with an implantable gentamicin-collagen sponge. JAMA 304:2123; author reply 2124.nde Bruin AF, Gosselink MP, van der Harst E, Rutten HJ. 2010. Local application of gentamicin collagen implants in the prophylaxis of surgical site infections following gastrointestinal surgery: a review of clinical experience. Tech Coloproctol 14:301-10.nDouville EC, Asaph JW, Dworkin RJ, et al. 2004. Sternal preservation: a better way to treat most sternal wound complications after cardiac surgery. Ann Thorac Surg 78:1659-64.nEklund A, Valtonen M, Werkkala K. 2005. Prophylaxis of sternal wound infections with gentamicin-collagen implant: randomized controlled study in cardiac surgery. J Hosp Infect 59:108-12.nFriberg Ö, Svedjeholm R, Söderquist B, Granfeldt H, Vikerfors T, Källman J. 2005. Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. Ann Thorac Surg 79:153-61.nFynn-Thompson F, Vander Salm TJ. 2004. Methods for reduction of sternal wound infection. Semin Thorac Cardiovasc Surg 16:77-80.nKinel FA, Ciaccio LA, Henderson SB. 1984. Sustained release preparations, XVI: collagen as a drug carrier. Arch Pharm 317:657-61.nLazar HL, Barlam T, Cabral H. 2011. The effect of topical vancomycin applied to sternotomy incisions on postoperative serum vancomycin levels. J Card Surg 26:461-5.nMoore RD, Lietman PS, Smith CR. 1987. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 155:93-9.nParsons LS. 2001. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the Twenty-sixth Annual SAS Users Group International Conference 2001, SAS Institute Inc., Cary, NC, April 22-25, 2001.nSchimmer C, Ozkur M, Sinha B, et al. 2012. Gentamicin-collagen sponge reduces sternal wound complications after heart surgery: a controlled, prospectively randomized, double-blind study. J Thorac Cardiovasc Surg 143:194-200.nStemberger A, Grimm H, Bader F, Rahn HD, Ascherl R. 1997. Local treatment of bone and soft tissue infections with the collagen-gentamicin sponge. Eur J Surg S578:17-26.nVander Salm TJ, Okike ON, Pasque MK, et al. 1989. Reduction of sternal infection by application of topical vancomycin. J Thorac Cardiovasc Surg 98:618-22.n
